knowledg
high
risk
human
papillomaviru
hpv
necessari
etiolog
factor
develop
cervic
cancer
provid
opportun
control
cervic
cancer
andor
hpvassoci
malign
vaccin
hpv
current
two
commerci
avail
prophylact
vaccin
gardasil
cervarix
base
upon
viruslik
particl
vlp
deriv
major
capsid
protein
effect
protect
infect
two
common
hpv
type
found
cervic
cancer
review
see
minor
capsid
antigen
also
show
promis
prevent
vaccin
anim
model
although
less
immunogen
vlp
howev
neither
vlp
vaccin
gener
therapeut
effect
establish
hpv
infect
therefor
given
signific
burden
hpvassoci
lesion
worldwid
urgent
need
develop
therapeut
hpv
vaccin
control
exist
hpv
infect
associ
malign
quit
differ
prevent
vaccin
target
viral
capsid
protein
andor
therapeut
hpv
vaccin
focu
target
hpv
sinc
oncoprotein
consist
express
hpvassoci
cancer
respons
malign
transform
among
variou
therapeut
hpv
vaccin
current
test
dna
vaccin
emerg
attract
candid
treatment
cervic
cancer
associ
malign
nake
dna
rel
safe
stabl
easi
produc
transport
review
see
furthermor
dna
vaccin
capabl
sustain
cellular
gene
express
promot
mhc
class
antigen
present
capac
repeat
administr
sinc
lead
gener
neutral
antibodi
howev
import
limit
dna
vaccin
limit
potenc
sinc
lack
intrins
abil
amplifi
spread
vivo
therefor
import
consid
strategi
improv
dna
vaccin
potenc
strategi
review
see
one
strategi
enhanc
dna
vaccin
potenc
improv
antigen
express
process
present
antigenpres
cell
use
intracellular
target
strategi
review
see
sever
previou
studi
employ
dna
vaccin
encod
calreticulin
crt
link
antigen
fusion
greatli
enhanc
cell
immun
respons
vaccin
mice
phenomenon
like
reflect
effici
recognit
calreticulin
dendrit
cell
improv
target
mhci
pathway
target
endoplasm
reticulum
activ
prolifer
cell
crucial
success
humor
cellmedi
respons
viral
infect
although
fusion
crt
enabl
dna
vaccin
elicit
signific
cell
immun
absenc
cell
help
approach
boost
cell
help
like
enhanc
dna
vaccin
potenc
inde
cell
play
signific
role
prime
effector
cell
thu
augment
cell
respons
well
gener
memori
cell
popul
review
see
cell
help
differenti
cell
effector
cell
provid
activ
signal
dendrit
cell
dc
notabl
thu
promot
cell
prolifer
thu
strategi
induc
helper
cell
site
cell
prime
potenti
enhanc
ctl
immun
respons
current
studi
aim
combin
intracellular
target
strategi
use
crt
strategi
enhanc
help
develop
therapeut
hpv
dna
vaccin
sinc
papillomaviru
antigen
like
contain
cell
epitop
reason
coadministr
vector
contain
codonoptim
bovin
papillomaviru
bpv
may
provid
cell
help
enhanc
antigenspecif
cell
immun
respons
gener
dna
vaccin
addit
potenti
benefit
would
induct
neutral
antibodi
protect
immun
show
coadministr
vector
contain
bpv
dna
combin
dna
vaccin
could
elicit
enhanc
antigenspecif
ovalbumin
ova
antigen
system
also
demonstr
coadministr
vector
contain
dna
dna
led
gener
cell
immun
respons
well
neutral
antibodi
furthermor
show
coadministr
significantli
enhanc
therapeut
antitumor
effect
gener
dna
vaccin
addit
observ
enhanc
cell
immun
respons
dna
encod
also
found
extend
system
overal
data
suggest
coadministr
dna
encod
papillomaviru
use
enhanc
antigenspecif
cell
immun
respons
gener
therapeut
hpv
dna
vaccin
control
hpv
infect
hpvassoci
tumor
furthermor
approach
also
gener
neutral
antibodi
papillomaviru
potenti
prevent
infect
strategi
also
provid
opportun
combin
prevent
therapeut
approach
strategi
may
potenti
extend
antigen
system
control
infect
andor
cancer
order
character
antigenspecif
cell
immun
respons
gener
vaccin
ova
dna
combin
vector
contain
codonoptim
dna
mice
five
per
group
vaccin
intraderm
via
gene
gun
ova
dna
without
dna
twice
interv
splenocyt
vaccin
mice
collect
week
last
immun
ovaspecif
cell
immun
respons
character
use
intracellular
cytokin
stain
follow
flow
cytometri
analysi
shown
fig
mice
vaccin
ova
dna
vaccin
combin
dna
gener
significantli
higher
ovaspecif
cell
immun
respons
compar
mice
vaccin
ova
dna
alon
evalu
whether
enhanc
antigenspecif
cell
immun
respons
coadministr
dna
also
observ
papillomaviru
system
coadminist
dna
ova
dna
vaccin
note
coadministr
dna
ova
dna
vaccin
also
gener
significantli
higher
cell
respons
compar
ova
dna
vaccin
alon
mice
fig
thu
data
indic
coadministr
papillomaviru
dna
significantli
enhanc
antigenspecif
cell
immun
respons
gener
dna
vaccin
order
determin
whether
coadministr
dna
dna
lead
gener
cell
immun
respons
mice
five
per
group
vaccin
intraderm
via
gene
gun
dna
dna
mice
vaccin
dna
alon
use
neg
control
splenocyt
vaccin
mice
collect
week
last
immun
incub
viruslik
particl
vlp
cell
immun
respons
character
use
intracellular
cytokin
stain
follow
flow
cytometri
analysi
shown
fig
b
mice
vaccin
combin
dna
led
gener
cell
immun
respons
similarli
vaccin
dna
led
signific
level
cell
immun
respons
compar
vaccin
alon
observ
whether
cell
respons
elicit
vaccin
strategi
extend
papillomaviru
system
coadminist
dna
ova
dna
vaccin
shown
fig
compar
vaccin
ova
dna
alon
mice
vaccin
dna
combin
ova
dna
led
gener
cell
immun
respons
result
suggest
coadministr
dna
encod
papillomaviru
dna
abl
gener
appreci
cell
immun
respons
respect
vaccin
mice
order
determin
observ
enhanc
antigenspecif
cell
immun
respons
coadministr
dna
translat
potent
therapeut
antitumor
effect
perform
vivo
tumor
treatment
experi
use
murin
tumor
cell
line
also
express
contain
either
mice
five
per
group
first
challeng
tumor
cell
subcutan
one
week
tumor
challeng
mice
treat
intraderm
via
gene
gun
dna
alon
dna
alon
dna
combin
dna
vaccin
mice
boost
twice
interv
dose
regimen
tumor
growth
monitor
twice
weekli
calip
measur
palpat
shown
fig
tumorbear
mice
treat
dna
vaccin
combin
dna
gener
significantli
reduc
tumor
volum
prolong
surviv
compar
mice
treat
dna
alon
dna
alon
thu
data
indic
coadministr
dna
capabl
significantli
enhanc
therapeut
antitumor
effect
gener
dna
vaccin
order
determin
mechan
underli
observ
enhanc
antigenspecif
cell
immun
respons
gener
coadministr
dna
vector
gener
encod
revers
sequenc
bpv
dna
bpv
mice
five
per
group
vaccin
intraderm
via
gene
gun
dna
without
revers
sequenc
dna
twice
interv
splenocyt
vaccin
mice
collect
week
last
immun
cell
immun
respons
character
use
intracellular
cytokin
stain
follow
flow
cytometri
analysi
found
mice
vaccin
dna
vaccin
combin
revers
sequenc
dna
lead
increas
frequenc
cell
immun
respons
observ
mice
vaccin
dna
dna
data
shown
insert
sequenc
express
activ
cell
help
therebi
enhanc
cell
respons
vaccin
result
suggest
cell
help
gener
coexpress
protein
promot
cell
immun
respons
dna
vaccin
order
determin
coadministr
dna
dna
lead
gener
neutral
antibodi
mice
three
per
group
immun
day
intraderm
via
gene
gun
andor
dna
vitro
neutral
assay
perform
use
pseudoviru
twofold
dilut
antisera
collect
mice
week
final
immun
mice
vaccin
combin
dna
found
gener
similar
neutral
antibodi
respons
compar
mice
vaccin
dna
alon
fig
final
evalu
whether
coadministr
papillomaviru
dna
elicit
potent
antigenspecif
cell
respons
appli
differ
rout
administr
mice
three
per
group
vaccin
intramuscularli
ova
dna
without
dna
twice
oneweek
interv
one
week
last
immun
pbmc
collect
ovaspecif
cell
immun
respons
character
flow
cytometri
analysi
shown
fig
mice
vaccin
intramuscularli
ova
dna
combin
dna
gener
significantli
higher
percentag
ovaspecif
cell
compar
mice
vaccin
intramuscularli
ova
dna
alon
data
indic
coadministr
papillomaviru
dna
lead
enhanc
antigenspecif
cell
immun
respons
intramuscular
rout
administr
current
studi
show
coadministr
vector
contain
codonoptim
combin
dna
vaccin
could
elicit
enhanc
antigenspecif
ovalbumin
ova
antigen
system
also
demonstr
coadministr
dna
dna
led
gener
cell
immun
respons
addit
observ
enhanc
cell
immun
respons
dna
also
confer
improv
therapeut
antitumor
effect
tumor
moreov
coadministr
dna
induc
gener
neutral
antibodi
may
serv
prevent
papillomaviru
infect
note
enhanc
antigenspecif
cell
respons
observ
intraderm
well
intramuscular
rout
administr
inde
alreadi
shown
vaccin
vector
express
protect
vagin
challeng
papillomaviru
pseudovirion
taken
togeth
studi
suggest
promis
approach
futur
clinic
translat
potenti
appli
antigen
system
show
cell
help
play
import
role
enhanc
antigenspecif
cell
immun
respons
observ
vaccin
regimen
coadministr
revers
sequenc
enhanc
antigenspecif
cell
respons
studi
shown
gener
much
effect
elicit
cell
respons
possibl
bpv
could
elicit
cell
respons
believ
cell
help
gener
dna
main
contributor
enhanc
antigenspecif
cell
respons
observ
furthermor
shown
cell
help
gener
memori
cell
though
current
studi
focus
character
antigenspecif
cell
therapeut
antitumor
effect
vaccin
strategi
interest
futur
studi
character
complet
effect
cell
abil
gener
memori
cell
respons
prolong
protect
vaccin
strategi
abl
gener
potent
therapeut
antitumor
effect
tumorbear
mice
interestingli
coadministr
dna
dna
gener
neutral
antibodi
confer
prophylact
valu
also
shown
vaccin
dna
induc
neutral
antibodi
balbc
mice
therefor
vaccin
strategi
coadministr
dna
gener
potent
antibodi
respons
one
genet
background
note
studi
shown
papillomaviru
gener
effect
gener
neutral
antibodi
thu
coadministr
dna
priorit
futur
translat
current
studi
show
coadministr
dna
led
potent
therapeut
antitumor
effect
prolong
surviv
due
enhanc
antigenspecif
cell
respons
cell
help
sinc
coadministr
dna
also
significantli
enhanc
antigenspecif
cell
respons
cell
help
believ
potent
therapeut
antitumor
effect
also
observ
promot
clinic
translat
subsequ
investig
focus
directli
character
antitumor
effect
coadministr
whether
revers
sequenc
abolish
antigenspecif
cell
respons
enhanc
conduct
addit
sinc
vaccin
regimen
achiev
complet
tumor
suppress
frequenc
vaccin
may
modifi
studi
determin
optim
vaccin
regimen
importantli
data
show
current
vaccin
strategi
gener
enhanc
antigenspecif
cell
respons
intraderm
intramuscular
vaccin
sinc
dna
vaccin
commonli
appli
intramuscularli
clinic
futur
translat
current
vaccin
technolog
may
focu
intramuscular
rout
administr
sever
strategi
employ
induc
helper
cell
enhanc
antigenspecif
cellmedi
immun
respons
gener
therapeut
hpv
dna
vaccin
previous
demonstr
dna
vaccin
encod
invari
chain
ii
class
iiassoci
invari
peptid
clip
region
replac
pan
hladr
bind
epitop
padr
could
elicit
potent
padrespecif
cell
respons
vaccin
mice
addit
coadministr
dna
construct
iipadr
dna
encod
gener
significantli
greater
cell
immun
respons
rel
coadministr
dna
encod
dna
encod
unmodifi
ii
thu
current
studi
repres
anoth
promis
approach
enhanc
help
improv
dna
vaccin
potenc
ad
benefit
induc
prophylact
immun
interest
futur
perform
headtohead
comparison
vector
contain
bpv
dna
iipadr
dna
abil
enhanc
antigenspecif
cell
respons
therapeut
hpv
dna
vaccin
inform
facilit
select
effect
desir
dna
construct
improv
dna
vaccin
potenc
anoth
potenti
mechan
enhanc
therapeut
hpv
dna
vaccin
potenc
coadministr
dna
potenti
format
vlp
transfect
cell
shown
express
lead
format
vlp
eukaryot
cell
furthermor
previou
studi
demonstr
papillomaviru
vlp
directli
activ
dendrit
cell
therebi
increas
express
costimulatori
marker
mhc
class
ii
molecul
thu
coadministr
dna
may
lead
local
activ
dc
result
enhanc
antigenspecif
cell
immun
respons
gener
dna
vaccin
howev
sinc
express
construct
similar
effect
dna
suggest
presenc
vlp
explain
enhanc
cell
respons
upon
coadministr
ova
construct
strategi
enhanc
cell
help
may
potenti
combin
strategi
enhanc
dna
vaccin
potenc
previous
demonstr
signific
enhanc
dna
vaccin
potenc
combin
strategi
prolong
dendrit
cell
life
intracellular
target
strategi
strategi
boost
cell
help
sinc
strategi
function
via
differ
mechan
combin
may
potenti
result
significantli
enhanc
antigenspecif
immun
respons
improv
antitumor
effect
clinic
translat
desir
identifi
best
combin
differ
strategi
order
achiev
best
dna
vaccin
potenc
summari
studi
demonstr
employ
dna
encod
papillomaviru
lead
gener
antigenspecif
cell
neutral
antibodi
result
improv
therapeut
prevent
hpv
dna
vaccin
potenc
strategi
may
potenti
extend
antigen
system
control
infect
andor
cancer
mice
week
old
purchas
nation
cancer
institut
frederick
md
anim
maintain
specif
pathogenfre
condit
john
hopkin
hospit
baltimor
md
procedur
perform
accord
john
hopkin
institut
care
use
committe
approv
protocol
accord
recommend
proper
care
laboratori
anim
cell
obtain
cotransform
primari
mous
lung
epitheli
cell
activ
ra
oncogen
describ
previous
maintain
rpmi
medium
supplement
mm
glutamin
mm
sodium
pyruv
mm
acid
hepe
iu
penicillin
streptomycin
fetal
bovin
serum
cultur
humidifi
incub
dna
construct
gener
describ
previous
dnacoat
gold
particl
prepar
describ
previous
dnacoat
gold
particl
deliv
shave
abdomin
region
mice
use
heliumdriven
gene
gun
biorad
laboratori
inc
hercul
ca
usa
discharg
pressur
psi
mice
immun
plasmid
dna
mous
encod
mix
deliv
shave
abdomen
mice
receiv
homolog
boost
week
later
splenocyt
harvest
mice
week
last
vaccin
prior
intracellular
cytokin
stain
splenocyt
vaccin
group
incub
h
epitop
rahynivtf
ova
peptid
isqavhaahaeineagr
vlp
presenc
golgiplug
bd
pharmingen
stimul
splenocyt
wash
facscan
buffer
stain
phycoerythrin
conjug
monoclon
rat
antimous
cell
subject
intracellular
cytokin
stain
use
cytofixcytoperm
kit
accord
manufactur
instruct
bd
pharmingen
intracellular
stain
fluorescein
isothiocyanateconjug
rat
antimous
identifi
immun
respons
cytokin
level
pbmc
collect
peripher
blood
week
last
intramuscular
vaccin
stain
antimous
ova
peptid
siinfekl
load
tetram
flow
cytometri
analysi
perform
use
facscalibur
cellquest
softwar
bd
bioscienc
mountain
view
ca
usa
mice
five
per
group
inocul
subcutan
tumor
cell
per
mous
left
flank
week
tumor
progress
usual
observ
mice
vaccin
dna
construct
conjunct
control
empti
vector
homolog
boost
administ
week
first
immun
mice
monitor
tumor
growth
measur
diamet
calip
twice
week
hpv
pseudovirion
encapsul
secret
alkalin
phosphatas
seap
gener
cotransfect
cell
plasmid
encod
hpv
seap
report
plasmid
describ
previous
cell
collect
transfect
treat
overnight
brij
benzonas
purifi
centrifug
optiprep
step
gradient
rpm
h
pseudoviru
neutral
assay
carri
outlin
previous
briefli
pseudoviru
pool
mous
immun
sera
incub
h
mixtur
use
infect
cell
h
postinfect
supernat
collect
seap
activ
supernat
measur
colorimetr
assay
serum
neutral
titer
defin
highest
dilut
caus
least
reduct
seap
activ
compar
control
preimmun
serum
sampl
data
express
mean
sd
repres
least
two
differ
experi
data
intracellular
cytokin
stain
flow
cytometri
analysi
tumor
treatment
experi
evalu
analysi
varianc
comparison
individu
data
point
made
use
student
ttest
p
valu
consid
signific
